Singapore - englanti - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - lignocaine hcl anhydrous - injection - 16 mg/ml

Euroopan unioni - englanti - myHealthbox

astrazeneca ab - metformin hydrochloride, dapagliflozin propanediol monohydrate - film-coated tablet (tablet) - 5 mg/850 mg - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose-lowering drugs - indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control - in patients inadequately controlled on their maximally tolerated dose of metformin alone - in combination with other glucose-lowering medicinal products, including insulin, in patients inadequately controlled with metformin and these medicinal products - in patients already being treated with the combination of dapagliflozin and metformin as separate tablets

Euroopan unioni - englanti - myHealthbox

astrazeneca ab - metformin hydrochloride, dapagliflozin propanediol monohydrate - film-coated tablet (tablet) - 5 mg/1,000 mg - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose-lowering drugs - indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control - in patients inadequately controlled on their maximally tolerated dose of metformin alone - in combination with other glucose-lowering medicinal products, including insulin, in patients inadequately controlled with metformin and these medicinal products - in patients already being treated with the combination of dapagliflozin and metformin as separate tablets

Filippiinit - englanti - FDA (Food And Drug Administration)

astrazeneca pharmaceutical co., ltd. - felodipine - extended-release tablet - 10 mg

Filippiinit - englanti - FDA (Food And Drug Administration)

astrazeneca pharmaceutical co., ltd. - felodipine - extended-release tablet - 5 mg

Filippiinit - englanti - FDA (Food And Drug Administration)

astrazeneca pharmaceutical co., ltd. - felodipine - extended-release tablet - 2.5 mg

Australia - englanti - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - glucose, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium bicarbonate; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 12 august 2003: glucose injection bp 10% is used in the treatment of carbohydrate and fluid depletion. glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. glucose injection bp 10% is used in preference to the 5% solution to provide adequate calories in a minimal volume of water and glucose injection bp 10% may also be used to treat hypoglycaemia.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - glucose, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium bicarbonate; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 4 april 2003: glucose injection bp 5% is used in the treatment of carbohydrate and fluid depletion. glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. glucose injection bp 5% may also be used to treat hypoglycaemia.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - morphine sulfate pentahydrate, quantity: 30 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 29 may 2020: morphine sulfate injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. morphine sulfate injection may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - morphine sulfate pentahydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 29 may 2020: morphine sulfate injection is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. morphine sulfate injection may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.